Face mask inactivating viruses and bacteria

该项目解决了为医护人员和急诊室人员提供可靠、可重复使用的高级个人防护装备的需求。具体目标是满足因新冠肺炎大流行而加剧的公众需求。根据英国皇家内科医学院（Royal College of Physicians）的数据，在英国，有四分之一的医生因为生病或自我隔离而不上班。在意大利，由于不戴口罩的人的数量和交通，大多数感染发生在医院的急诊室。总体而言，感染covid - 19的人中有10%是医护人员。这增加了NHS和其他国家卫生组织的压力，特别是在大流行期间。**具体的创新**是一个防止病毒和细菌的口罩。这款新奇的口罩是由多个不同医学领域的技术诀窍结合而成的。这种口罩不仅能过滤掉有害的病原体，还能灭活它们，使病毒无法发病。该方法的独特之处在于它结合了两种主要PPE类型的最佳方面：a)基于普通过滤器的面罩-轻便便携，物有所值，提供可重复使用的模型b)基于SCBA的PPE（例如危险品服）-提供最高等级的个人保护，适合在高风险环境中工作目前的发明轻巧便携，同时还提供增强的保护，如基于SCBA的PPE。本发明解决了基于过滤器的口罩（ssRNA病毒比最高级外科口罩中的过滤器小6-10倍，如N95）和SCBA设备的缺点，即一次性使用且非常昂贵。我们的目标人群包括急症室工作人员、高级护理人员和紧急医疗技术人员、流行病期间的全科医生、所有其他医护人员、急症室的访客。“影响扩展”流程符合我们的目标，即扩大我们的HFEF防护面罩，以达到特定的市场利基。额外的资金将增加创新的影响和推向市场的速度。我们的主要市场将是英国和美国的急症室员工和全科医生。我们使用无晶圆厂的商业模式，使我们能够从较低的资本成本中受益，同时将他们的研发资源集中在终端市场上。我们的团队成员拥有实施地平线2020项目的经验，并在商业和战略、市场营销和销售、工程和产品设计以及连续创业方面提供独特的技能组合。

The project addresses the need for reliable, re-usable, high-grade PPE for HCW and people in emergency rooms. The specific aim is to satisfy the public need exacerbated by the COVID19 pandemic. In the U.K., one in four doctors is off work because they are either sick or in self-isolation, according to the Royal College of Physicians. In Italy, most infections occurred in hospital emergency rooms due to the volume & traffic of people without masks. Overall, 10% of those infected with COVID19, were HCWs. This increases the strain on the NHS and other National Health organisations, especially during a pandemic.**The specific innovation** is a face mask for protection against viruses and bacteria. The novelty of the mask is created by a combination of know-how from a number of different medical fields. The mask does not simply filter out harmful pathogens, but also inactivates them, rendering viruses incapable of pathogenesis. The approach is unique in the way it combines the best aspects of the two main types of PPE:a) Common filter based face masks -- light and portable, value for money, offers reusable modelsb) SCBA based PPE (for example hazmat suit) -- offers the highest grade of personal protection, suitable for work in high-risk environmentsThe current invention is light and portable while also offering enhanced protection like SCBA-based PPE. The invention solves the drawbacks of filter-based masks (ssRNA viruses are 6-10X smaller than the filters in the highest grade surgical masks, like N95) and of SCBA equipment, which is single-use and exceptionally expensive.Our target groups include A&E staff, Advanced Paramedic and Emergency Medical Technicians, GPs during an epidemic, all other HCWs, visitors to A&E rooms.“Extension for Impact” process aligns with our goal to scale our HFEF protective mask to reach specific market niches. The additional funding will increases the innovation’s impact and speed to market.Our Primary market will be A&E staff and GPs in the UK and the US. We use the fabless business model allowing us to benefit from lower capital costs while concentrating their research and development resources on the end market. Our team members have experience in implementing Horizon 2020 projects and offer a unique combination of skills in business and strategy, marketing & sales, engineering, and product design, and serial entrepreneurship.